Table 2. The Most Frequently Prescribed Psychotropic Polypharmacy Patterns Among Youths Treated With Psychotropic Polypharmacya.
| Polypharmacy combinations | Weighted % (95% CI) |
|---|---|
| 1999-2004 | |
| Atd, Sti, Msb | 17.8 (6.5-29.0) |
| Atd, Sti, Aag | 15.1 (5.0-25.1) |
| Atp, Sti, Aag | 11.8 (1.3-22.4) |
| Sti, Msb, Aag | 9.7 (2.5-16.8) |
| 2005-2010 | |
| Atp, Atd, Sti | 21.6 (12.9-30.2) |
| Atp, Sti, Aag | 17.4 (7.7-17.0) |
| Atp, Sti, Msb | 11.8 (5.8-17.8) |
| Atd, Sti, Aag | 10.4 (3.9-16.9) |
| 2011-2015 | |
| Atp, Sti, Aag | 21.8 (13.7-29.8) |
| Atp, Atd, Sti | 16.7 (8.7-24.6) |
| Atd, Sti, Aag | 13.9 (7.4-20.4) |
| Atp, Atd, Msb | 9.9 (3.3-16.6) |
Abbreviations: Aag, α-agonists; Atd, antidepressants; Atp, antipsychotics; Msb, mood stabilizers; Sti, stimulants.
a
Only combinations reported in 10% or more of youths treated with psychotropic polypharmacy were presented.